The Indian primary stock market is going to experience a lot of interesting IPO activities in December 2024. With the IPOs of both Mainboard and SME, there is much to look at. Here is the detailed calendar of IPOs that will be issued in December 2024, including the dates for opening and closing, issue prices, and the size of the issues by different companies.

Mainboard IPOs-December 2024

Mainboard IPOs, for December, are the big-ticket events with some notable companies entering the public sector. The list includes;

Suraksha Diagnostic Limited IPO

Suraksha Diagnostic Limited is one of the leading companies in the diagnostic industry, which is going to make its mark on the capital market with its much-awaited Initial Public Offering (IPO). The IPO consists of 19,189,330 equity shares of face value of ₹2 each. It is going to raise up to ₹846.25 crore. Here's an in-depth view of this upcoming IPO and why it has garnered significant attention among investors.

Key Highlights of the Suraksha Diagnostic IPO

IPO Size: ₹846.25 crore

Price Band: ₹420 - ₹441 per equity share

Issue Type: Offer-for-Sale (OFS)

Opening Date: November 29, 2024

Closing Date: December 3, 2024

Listing at: BSE and NSE

This is purely an Offer-for-Sale (OFS), where the proceeds go to the existing shareholders - promoters and investors who are selling their stakes.

About Suraksha Diagnostic Limited

Suraksha Diagnostic Limited has emerged as a leading name in the healthcare and diagnostics segment since its incorporation in 2005. The company offers an array of services from the Kolkata base, including pathology testing, radiology services, and medical consultancy.

Suraksha Diagnostic Limited has been able to establish its dominance in eastern India. It has a:

Central reference laboratory that serves as the flagship facility.

8 satellite laboratories, which help to operate smoothly.

215 customer touchpoints that include:

49 diagnostic centers providing full medical services.

166 collection centers, above all franchised, covering a large population base

Suraksha Diagnostic has its own network, covering West Bengal, Bihar, Assam, and Meghalaya, serving millions of patients every year. On June 30, 2024, the company's strong infrastructure made it one of the leaders in the diagnostics sector.

Investment Highlights

Market Leadership in Eastern India: Suraksha Diagnostic is a leading brand in the eastern region where healthcare and diagnostic services are fast in demand.

Established Network: The company's wide network makes it accessible and convenient for customers, which adds to its steady revenue growth.

Seasoned Management: Suraksha Diagnostic has a team of seasoned professionals in healthcare and diagnostics.

Growth Potential: The Indian diagnostic market is expected to witness significant growth in the near future, leaving enough scope for growth for players like Suraksha Diagnostic.

centers

The primary goals of the IPO are:

To facilitate the Offer-for-Sale by existing shareholders, including the promoters and private equity investors.

To list its equity shares on BSE and NSE, enhancing liquidity and shareholder value.

Should You Invest in Suraksha Diagnostic IPO?

Investors who want to create diversification in their investment portfolio with exposure to healthcare and diagnostics sectors must look for this IPO. Due to its strong market, operational efficiency, and established brands, Suraksha Diagnostic seems to be a remarkable opportunity for the Indian stock exchange.

How to Apply for Suraksha Diagnostic IPO?:

Investors can apply for an IPO through the IPO Ji App or website or ASBA (Applications Supported by Blocked Amount) or even by trading platforms like Zerodha, Upstox, and other such brokerages.

Property Share Investment Trust REIT

It's a more intelligent and convenient approach toward wealth-building in real estate investing. One great opportunity for you, knocking right at your doorstep, is Property Share Investment Trust SM REIT. It's opening its books on December 2, 2024. With the price band of ₹10,00,000 - ₹10,50,000, it promises to be ₹353 crore. Thus, this is going to create a bang and also redefine investment into the sector.

This blog answers all your questions about REITs and why Property Share SM REIT is a must-consider investment if you are looking to diversify your portfolio, earn steady passive income, or get exposure to real estate without owning property.

What Are REITs?

Real Estate Investment Trusts, or REITs, are companies that own, operate, or finance income-generating real estate properties. They pool money from several investors to buy and manage large-scale properties, such as office spaces, shopping malls, apartments, or warehouses.

Think of REITs as the stock market for real estate—just as you can buy shares in a company, you can own a share of large real estate projects through REITs.

Advantages of Investing in REITs

1. Regular Income: REITs distribute a large portion of their rental income as dividends to investors, thus providing regular returns.
2. Portfolio Diversification: Investing in REITs spreads your risk across multiple properties and real estate sectors, reducing dependency on a single asset.
3. Liquidity: Unlike physical property, REITs are traded on stock exchanges, allowing you to buy or sell shares easily.
4. Transparency: The SEBI norms would provide transparency into the operation of REITs, clearly mentioning their discloses and reporting of finance.
5. Affordability: Gone are the millions for that house. REITs now help you invest a smaller amount to gain exposure in the premium property.
   

SM Property Share Investment Trust REIT: Why Invest?

This is one of the most popular and talked about the REITs in 2024 market. It comes with the following features

1. Strategic Fundraising: This REIT will raise ₹353 crores to fund premium real estate developments in high-growth locations.
2. Prime Assets: It is backed by high-value properties in key urban areas, ensuring long-term appreciation in value and stable rental income.
3. Accessible Investment: A price band of ₹10,00,000 to ₹10,50,000 makes it suitable for investors looking for significant returns without breaking the bank.

How Does It Work?

With Property Share SM REIT, the money you invest is pooled with that of other investors to buy, manage, or develop properties. These properties generate rental income, which is distributed as dividends to shareholders. Moreover, the value of the properties appreciated should further appreciate the value of your investments.

Who Should Invest?

✅Passive Income Seekers: Want steady cash flow without the headache of managing tenants or maintenance? REITs are perfect.

✅First-Time Investors: Get into real estate investing without having to purchase a physical property.

✅Portfolio Diversifiers: You already invest in stocks, mutual funds, or bonds. REITs can help you stabilize your portfolio and avoid the more volatile price movements.

✅Seasoned Investors: Want to find a regulated and tax-efficient form of real estate? Add this REIT to deepen your investments.

Sai Life Sciences Limited IPO

The pharmaceutical firm is an upcoming IPO to be presented by the company to the masses. The size of the issue is ₹3,042.62 crore, for which the companies are set to open the opportunity for those who want to be an investor in it, considering it as an investment area for growth-oriented leading organizations.

Here are the following details about the IPO including dates of the IPO and investment aspects.

Sai Life Sciences IPO Details:

The Sai Life Sciences IPO is an ₹3,042.62 crore book-built issue that encompasses:
Fresh Issue: 1.73 crore equity shares aggregating ₹950.00 crores.
Offer for Sale (OFS): 3.81 crore shares aggregating ₹2,092.62 crores
IPO funds raised from fresh issues would be used for promoting the growth of the company, whereas in OFS, the shareholders would be able to reduce the percentage of their shareholdings by selling a portion of them.

Important Dates of Sai Life Sciences IPO

Issue Opens: December 11, 2024
Closing of Subscription: December 13, 2024
Allotment Date: December 16, 2024
Listing Date: December 18, 2024 (on BSE and NSE)

Price Band and Lot Sizes

Price Band: ₹522 to ₹549 per equity share.
Minimum Lot Size: 27 shares.

Investment Amount for Sai Life Sciences:

Retail Investors: one lot consisting of 27 equity shares with a minimum amount of ₹14,823
Small Non-Institutional Investors (sNII): 14 lots consisting of 378 equity shares with a minimum amount of ₹207,522
Big Non-Institutional Investors (bNII): 68 lots consisting of 1,836 equity shares with a minimum amount of ₹1,007,964

Lead Managers and Registrar

The IPO process is executed by a team of experienced Book Running Lead Managers. It has ensured that the process should be smooth and without any glitches in its execution:

Kotak Mahindra Capital Company Limited
Jefferies India Private Limited
Morgan Stanley India Company Pvt Ltd
IIFL Securities Ltd

KFin Technologies Limited has been appointed for the role of registrar for this issue. Allotment/Refund will be coordinated by this registrar.

Sai Life Sciences is an established pharmaceutical company with a global presence and a diversified client base comprising 18 of the top 25 pharmaceutical companies globally. The IPO gives an opportunity to invest in a growth-oriented company with a robust track record and significant expertise in small-molecule new chemical entities.

Before investing, one should consider the pricing, lot size, and investment goals. As in any IPO, a good analysis of the company's fundamentals and growth potential is advisable.

SME IPOs – December 2024

December 2024 is going to be a busy time for investors who want to invest in the dynamic world of SME IPOs. SME IPOs enable small and medium-sized enterprises to raise capital from the public while offering investors an opportunity to become a part of the growth story of emerging enterprises.